Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study

被引:120
作者
Bandosz, Piotr [1 ]
O'Flaherty, Martin [2 ]
Drygas, Wojciech [3 ]
Rutkowski, Marcin [1 ]
Koziarek, Jacek [3 ]
Wyrzykowski, Bogdan [1 ]
Bennett, Kathleen [4 ]
Zdrojewski, Tomasz [1 ]
Capewell, Simon [2 ]
机构
[1] Med Univ Gdansk, Dept Hypertens & Diabetol, PL-80211 Gdansk, Poland
[2] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England
[3] Inst Cardiol, CVD Prevent & Hlth Promot, Dept Epidemiol, PL-04635 Warsaw, Poland
[4] St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland
来源
BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 344卷
基金
英国医学研究理事会;
关键词
RISK-FACTORS; TRENDS; RATES; SENSITIVITY; DECREASE; CARE;
D O I
10.1136/bmj.d8136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To examine how much of the observed rapid decrease in mortality from coronary heart disease in Poland after the political, social, and economic transformation in the early 1990s could be explained by the use of medical and surgical treatments and how much by changes in cardiovascular risk factors. Design A modelling study. Setting Sources of data included controlled trials and meta-analyses, national surveys, and official statistics. Participants Population of adults aged 25-74 in Poland in 1991-2005. Main outcome measures Number of deaths prevented or postponed in 2005 attributable to specific treatments for coronary heart disease and changes in risk factors. A previously validated epidemiological model for coronary heart disease was used to combine and analyse data on the uptake and effectiveness of specific cardiac treatments and changes in risk factors. The observed fall in deaths from coronary heart disease from 1991 to 2005 was then partitioned among specific treatments and risk factor changes. Results From 1991 to 2005, the death rate from coronary heart disease in Poland halved, resulting in 26 200 fewer coronary deaths in 2005 in people aged 25-74. About 37% (minimum estimate 13%, maximum estimate 77%) of this decrease was attributable to treatments, including treatments for heart failure (12%), initial treatments for acute coronary syndrome (9%), secondary prevention treatments after myocardial infarction or revascularisation (7%), chronic angina treatments (3%), and other treatments (6%). About 54% of the fall was attributed to changes in risk factors (minimum estimate 41%, maximum estimate 65%), mainly reductions in total cholesterol concentration (39%) and an increase in leisuretime physical activity (10%); however, these were partially offset by increases in body mass index (-4%) and prevalence of diabetes (-2%). Blood pressure fell in women, explaining about 29% of their decrease in mortality, but rose in men generating a negative influence (-8%). About 15% of the observed decrease in mortality was attributable to reduced smoking in men but was negligible in women. Conclusions Over half of the recent fall in mortality from coronary heart disease in Poland can be attributed to reductions in major risk factors and about one third to evidence based medical treatments.
引用
收藏
页数:10
相关论文
共 40 条
  • [1] [Anonymous], OP DAT
  • [2] Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006
    Aspelund, Thor
    Gudnason, Vilmundur
    Magnusdottir, Bergrun Tinna
    Andersen, Karl
    Sigurdsson, Gunnar
    Thorsson, Bolli
    Steingrimsdottir, Laufey
    Critchley, Julia
    Bennett, Kathleen
    O'Flaherty, Martin
    Capewell, Simon
    [J]. PLOS ONE, 2010, 5 (11):
  • [3] MEDICAL-MANAGEMENT AND THE DECLINE IN MORTALITY FROM CORONARY HEART-DISEASE
    BEAGLEHOLE, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6512): : 33 - 35
  • [4] Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
    Bjorck, Lena
    Rosengren, Annika
    Bennett, Kathleen
    Lappas, George
    Capewell, Simon
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (09) : 1046 - 1056
  • [5] Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002
  • [6] UNCERTAINTY IN THE ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES - THE ROLE OF SENSITIVITY ANALYSIS
    BRIGGS, A
    SCULPHER, M
    BUXTON, M
    [J]. HEALTH ECONOMICS, 1994, 3 (02) : 95 - 104
  • [7] Broda Grazyna, 2005, Kardiol Pol, V63, pS601
  • [8] Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
    Capewell, S
    Morrison, CE
    McMurray, JJ
    [J]. HEART, 1999, 81 (04) : 380 - 386
  • [9] Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993
    Capewell, S
    Beaglehole, R
    Seddon, M
    McMurray, J
    [J]. CIRCULATION, 2000, 102 (13) : 1511 - 1516
  • [10] Rapid mortality falls after risk-factor changes in populations
    Capewell, Simon
    O'Flaherty, Martin
    [J]. LANCET, 2011, 378 (9793) : 752 - 753